Philips partners with Nuvo Group for remote pregnancy monitoring and more digital health briefs

Med tech large Royal Philips is partnering with Nuvo Team to aid distant being pregnant checking in rural spots.

The collaboration will commence with a pilot application in rural Colorado using Nuvo’s INVU remote checking method, which was cleared by the Fda last yr. The firms say the application could increase access to maternity treatment in rural communities, the place a absence of choices contributes to even worse outcomes and higher mortality rates. 

“Digital methods and ecosystem-creating are essential enablers to addressing disparities in healthcare these types of as entry to maternal health and fitness care in rural configurations,” Sandra Lesenfants, general supervisor, hospital affected person monitoring, at Philips, reported in a assertion. “With this collaboration, we are extending the sight and get to of being pregnant treatment and bringing additional distant checking possibilities to the communities and expectant moms where by and when they will need them most.”


Prescription electronic therapeutics firm Pear Therapeutics will now be readily available in Epic’s App Orchard Gallery, permitting providers to observe people employing the company’s therapeutics in just the EHR.

Together with the PearConnect services platform in the gallery will enhance workflows for vendors as they handle people employing reSET or reSET-O for compound use and opioid use diseases, the organization mentioned. They are going to be ready to review client progress and document distant monitoring get the job done for reimbursement.

“We are enthusiastic to bring this opportunity to increase entry to our PDTs, with the preliminary listing of our PearConnect system in the App Orchard gallery to assistance reSET and reSET-O people. We think Pear’s integration with Epic will make a pathway for health care suppliers to conveniently entry our PearConnect platform and help scale to serve several additional individuals,” Pear chief industrial officer Julia Strandberg explained in a assertion.


Virtual reality therapeutics startup AppliedVR announced it has altered the title of its EaseVRx therapeutic to RelieVRx.

The technique gained Food and drug administration De Novo clearance to address persistent lower back again discomfort in November. AppliedVR strategies to launch the rebranded RelieVRx in a several marketplaces this yr to prepare for its complete launch in 2023. 

“While relieve of use is unquestionably an vital aspect of our style and design, in the long run we wished a identify that far better reflected how our revolutionary product intends to provide daily life-transforming relief. With demonstrated efficacy info, ‘RelieVRx’ improved captures the core advantage of soreness aid that the health care marketplace is looking for: a prescription treatment selection that presents a exceptional modality when addressing unmet individual desires,” cofounder and CEO Matthew Stoudt stated in a assertion. 

The company also declared it experienced appointed Dr. Charisse Y. Sparks as chief professional medical officer to help the RelieVRx start and its opportunity enlargement for other scientific demands. Sparks most recently worked at DePuySynthes, the orthopedic device arm of Johnson & Johnson.

“Racial, ethnic and economic disparities in serious ache management are nicely recognized. Responsible research display that these disparities present up in the undertreatment of ache as effectively as overdose deaths, which continue to maximize,” Sparks claimed in a statement. “I am searching forward to earning immersive therapeutics a standard of treatment in continual suffering management and setting up AppliedVR as a leader in health and fitness equity for the digital wellbeing business.”